Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors https://ift.tt/eA8V8J

Covishield is less expensive compared to some of the other vaccines being used — such as the ones from Pfizer-BioNTech and Moderna.

from The Hindu - National https://ift.tt/37GjPGn